178 related articles for article (PubMed ID: 33221677)
1. Haplobanking induced pluripotent stem cells for clinical use.
Sullivan S; Fairchild PJ; Marsh SGE; Müller CR; Turner ML; Song J; Turner D
Stem Cell Res; 2020 Dec; 49():102035. PubMed ID: 33221677
[TBL] [Abstract][Full Text] [Related]
2. Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations.
Lee S; Huh JY; Turner DM; Lee S; Robinson J; Stein JE; Shim SH; Hong CP; Kang MS; Nakagawa M; Kaneko S; Nakanishi M; Rao MS; Kurtz A; Stacey GN; Marsh SGE; Turner ML; Song J
Stem Cells; 2018 Oct; 36(10):1552-1566. PubMed ID: 30004605
[TBL] [Abstract][Full Text] [Related]
3. The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines.
Gourraud PA; Gilson L; Girard M; Peschanski M
Stem Cells; 2012 Feb; 30(2):180-6. PubMed ID: 22045598
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells.
Álvarez-Palomo B; García-Martinez I; Gayoso J; Raya A; Veiga A; Abad ML; Eiras A; Guzmán-Fulgencio M; Luis-Hidalgo M; Eguizabal C; Santos S; Balas A; Alenda R; Sanchez-Gordo F; Verdugo LP; Villa J; Carreras E; Vidal F; Madrigal A; Herrero MJ; Rudilla F; Querol S
Stem Cell Res Ther; 2021 Apr; 12(1):233. PubMed ID: 33849662
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the Hematopoietic Stem Cell Donor Pool as a Source of HLA-Homozygous Induced Pluripotent Stem Cells for Haplobanking: Combined Analysis of the Cord Blood Inventory and Bone Marrow Donor Registry.
Shin S; Song EY; Kwon YW; Oh S; Park H; Kim NH; Roh EY
Biol Blood Marrow Transplant; 2020 Aug; 26(8):e202-e208. PubMed ID: 32439474
[TBL] [Abstract][Full Text] [Related]
6. Proceedings: human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the california population: evaluating matching in a multiethnic and admixed population.
Pappas DJ; Gourraud PA; Le Gall C; Laurent J; Trounson A; DeWitt N; Talib S
Stem Cells Transl Med; 2015 May; 4(5):413-8. PubMed ID: 25926330
[TBL] [Abstract][Full Text] [Related]
7. Generation of a bank of clinical-grade, HLA-homozygous iPSC lines with high coverage of the Spanish population.
Kuebler B; Alvarez-Palomo B; Aran B; Castaño J; Rodriguez L; Raya A; Querol Giner S; Veiga A
Stem Cell Res Ther; 2023 Dec; 14(1):366. PubMed ID: 38093328
[TBL] [Abstract][Full Text] [Related]
8. Umbilical Cord Blood Units Cryopreserved in the Public Cord Blood Bank: A Breakthrough in iPSC Haplobanking?
Roh EY; Oh S; Yoon JH; Kim BJ; Song EY; Shin S
Cell Transplant; 2020; 29():963689720926151. PubMed ID: 32623908
[TBL] [Abstract][Full Text] [Related]
9. Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations.
Zimmermann A; Preynat-Seauve O; Tiercy JM; Krause KH; Villard J
Stem Cells Dev; 2012 Sep; 21(13):2364-73. PubMed ID: 22559254
[TBL] [Abstract][Full Text] [Related]
10. Immunological considerations for embryonic and induced pluripotent stem cell banking.
Taylor CJ; Bolton EM; Bradley JA
Philos Trans R Soc Lond B Biol Sci; 2011 Aug; 366(1575):2312-22. PubMed ID: 21727137
[TBL] [Abstract][Full Text] [Related]
11. Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types.
Taylor CJ; Peacock S; Chaudhry AN; Bradley JA; Bolton EM
Cell Stem Cell; 2012 Aug; 11(2):147-52. PubMed ID: 22862941
[TBL] [Abstract][Full Text] [Related]
12. Creating an HLA-homozygous iPS cell bank for the Brazilian population: Challenges and opportunities.
Martins de Oliveira ML; Tura BR; Meira Leite M; Melo Dos Santos EJ; Pôrto LC; Pereira LV; Campos de Carvalho AC
Stem Cell Reports; 2023 Oct; 18(10):1905-1912. PubMed ID: 37774702
[TBL] [Abstract][Full Text] [Related]
13. Impact of Homozygous Conserved Extended HLA Haplotype on Single Cord Blood Transplantation: Lessons for Induced Pluripotent Stem Cell Banking and Transplantation in Allogeneic Settings.
Morishima Y; Morishima S; Murata M; Arima N; Uchida N; Sugio Y; Takahashi S; Matsuhashi Y; Onizuka M; Eto T; Nagafuji K; Onishi Y; Inoue M; Atsuta Y; Fukuda T; Ichinohe T; Kato S; Kanda J
Biol Blood Marrow Transplant; 2020 Jan; 26(1):132-138. PubMed ID: 31521817
[TBL] [Abstract][Full Text] [Related]
14. A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population.
Yoshida S; Kato TM; Sato Y; Umekage M; Ichisaka T; Tsukahara M; Takasu N; Yamanaka S
Med; 2023 Jan; 4(1):51-66.e10. PubMed ID: 36395757
[TBL] [Abstract][Full Text] [Related]
15. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors.
Sugita S; Iwasaki Y; Makabe K; Kimura T; Futagami T; Suegami S; Takahashi M
Stem Cell Reports; 2016 Oct; 7(4):619-634. PubMed ID: 27641646
[TBL] [Abstract][Full Text] [Related]
16. MHC matching improves engraftment of iPSC-derived neurons in non-human primates.
Morizane A; Kikuchi T; Hayashi T; Mizuma H; Takara S; Doi H; Mawatari A; Glasser MF; Shiina T; Ishigaki H; Itoh Y; Okita K; Yamasaki E; Doi D; Onoe H; Ogasawara K; Yamanaka S; Takahashi J
Nat Commun; 2017 Aug; 8(1):385. PubMed ID: 28855509
[TBL] [Abstract][Full Text] [Related]
17. HLA-based banking of induced pluripotent stem cells in Saudi Arabia.
Alowaysi M; Lehmann R; Al-Shehri M; Baadhaim M; Alzahrani H; Aboalola D; Zia A; Malibari D; Daghestani M; Alghamdi K; Haneef A; Jawdat D; Hakami F; Gomez-Cabrero D; Tegner J; Alsayegh K
Stem Cell Res Ther; 2023 Dec; 14(1):374. PubMed ID: 38111036
[TBL] [Abstract][Full Text] [Related]
18. [Present and Future of an iPS Cell Stock for Regenerative Medicine].
Hanatani T; Takasu N
Rinsho Byori; 2017 Feb; 65(2):160-166. PubMed ID: 30762982
[TBL] [Abstract][Full Text] [Related]
19. Capacity of Retinal Ganglion Cells Derived from Human Induced Pluripotent Stem Cells to Suppress T-Cells.
Edo A; Sugita S; Futatsugi Y; Sho J; Onishi A; Kiuchi Y; Takahashi M
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105725
[TBL] [Abstract][Full Text] [Related]
20. Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy.
de Rham C; Villard J
J Immunol Res; 2014; 2014():518135. PubMed ID: 25126584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
